Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile

被引:35
|
作者
Jaiswal, Kshama [1 ,2 ]
Hull, Madelyne [3 ]
Furniss, Anna L. [4 ]
Doyle, Reina [5 ]
Gayou, Natalia [5 ]
Bayliss, Elizabeth [6 ,7 ]
机构
[1] Univ Colorado, Dept Surg, Sch Med, Aurora, CO USA
[2] Denver Hlth Med Ctr, Dept Surg, 777 Bannock St,MC 0206, Denver, CO 80204 USA
[3] Denver Hlth Med Ctr, Dept Med, Denver, CO USA
[4] Univ Colorado, Sch Med, ACCORDS, Aurora, CO USA
[5] Denver Hlth Med Ctr, Hlth Serv Res, Denver, CO USA
[6] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[7] Univ Colorado, Sch Med, Dept Family Med, Denver, CO USA
关键词
ADJUVANT CHEMOTHERAPY; AFRICAN-AMERICAN; NATIONAL BREAST; WAIT TIMES; RADIOTHERAPY; TIMELINESS; INITIATION; COHORT; WOMEN; CARE;
D O I
10.6004/jnccn.2018.7067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Timely detection and treatment of breast cancer is important in optimizing survival and minimizing recurrence. Given disparities in breast cancer outcomes based on socioeconomic status, we examined time to diagnosis and treatment in a safety-net hospital. Methods: We conducted a retrospective review of all patients with breast cancer diagnosed between July 1, 2010, and June 30, 2012 (N=120). We limited our analytic sample to patients with nonrecurrent, primary stage 0-III breast cancer (N=105) and determined intervals from presentation to diagnosis, diagnosis to first treatment, last surgery to chemotherapy initiation, and last surgery to start of radiation therapy (RT). Using logistic regression, we calculated unadjusted odds of receiving timely treatment (< median time) versus more delayed treatment (>= median time) as a function of age, language, ethnicity, insurance, Charlson comorbidity index, disease stage, method of first presentation (screening mammography vs care provider), symptoms at presentation, and type of surgical treatment. Results: Patients aged 55 to 64 years accounted for most of the sample (n=37; 35.2%). Median time from presentation to diagnosis (23 days), time from diagnosis to first treatment, and time from surgery to chemotherapy initiation fell within intervals published in the literature; median time from last surgery to start of RT was greater than recommended intervals. Factors significantly associated with longer intervals than median time included stage, method of presentation, language, surgical treatment, insurance, and ethnicity. Conclusions: Patients in this safety-net setting experienced acceptable diagnosis and treatment intervals, except for time to RT. Focused interventions that help care providers access imaging quickly for their symptomatic patients could improve time to diagnosis. Concentrating additional efforts on non-English-speaking, Hispanic patients and those who need to receive RT could improve time to treatment.
引用
收藏
页码:1451 / 1457
页数:7
相关论文
共 50 条
  • [31] CAN A WEB-BASED TRACKING & FEEDBACK TOOL IMPROVE BREAST CANCER TREATMENT AT SAFETY-NET HOSPITALS?
    Bickell, Nina A.
    Castaldi, Maria
    Shah, Ajay
    Sickles, Alan
    Lewis, Theophilus
    Arora, Shalini
    Clarke, Kevin
    Pappas, Peter
    Kemeny, Margaret
    Srinivasan, Anitha
    Franco, Rebeca
    Fei, Kezhen
    Parides, Michael
    McAlearney, Ann S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S132 - S133
  • [32] Evaluation of cardiotoxicity related to cancer treatment in an urban safety-net hospital.
    Lee, Michelle Jeung-Eun
    Chang, Eric
    Onwuanyi, Anekwe
    Jain, Sanjay R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital
    Yu, Karina
    Westbrook, Marisa
    Brodie, Shauna
    Lisker, Sarah
    Vittinghoff, Eric
    Hua, Vivian
    Russell, Marika
    Sarkar, Urmimala
    OTO OPEN, 2020, 4 (01)
  • [34] Quality of life and cervical cancer chemoradiation treatment compliance at a safety-net hospital
    Yu, Xiaoman
    Case, Elizabeth Sult
    Yoder, Alison
    Ludwig, Michelle
    Montealegre, Jane
    Echeverria, Alfredo
    Sharma, Shelly
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S247 - S247
  • [35] Survivorship Care Plan Information Needs: Perspectives of Safety-Net Breast Cancer Patients
    Burke, Nancy J.
    Napoles, Tessa M.
    Banks, Priscilla J.
    Orenstein, Fern S.
    Luce, Judith A.
    Joseph, Galen
    PLOS ONE, 2016, 11 (12):
  • [36] Disparities in Laryngeal Cancer Treatment and Outcomes: An Analysis by Hospital Safety-Net Burden
    Qureshi, Muhammad M.
    Oladeru, Oluwadamilola T.
    Lam, Christa M.
    Dyer, Michael A.
    Mak, Kimberley S.
    Hirsch, Ariel E.
    Truong, Minh Tam
    LARYNGOSCOPE, 2021, 131 (06): : E1987 - E1997
  • [37] Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals
    Dhar, Vikrom K.
    Hoehn, Richard S.
    Kim, Young
    Xia, Brent T.
    Jung, Andrew D.
    Hanseman, Dennis J.
    Ahmad, Syed A.
    Shah, Shimul A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (01) : 98 - 106
  • [38] EQUIVALENT TREATMENT AND SURVIVAL AFTER RESECTION OF PANCREATIC CANCER AT SAFETY-NET HOSPITALS
    Dhar, Vikrom K.
    Hoehn, Richard S.
    Kim, Young
    Xia, Brent
    Jung, Andrew
    Hanseman, Dennis J.
    Ahmad, Syed
    Shah, Shimul A.
    GASTROENTEROLOGY, 2017, 152 (05) : S1210 - S1210
  • [39] Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden
    Sridhar, Praveen
    Bhatt, Maunil
    Qureshi, Muhammad M.
    Asokan, Sainath
    Truong, Minh Tam
    Suzuki, Kei
    Mak, Kimberley S.
    Litle, Virginia R.
    ANNALS OF THORACIC SURGERY, 2019, 107 (05): : 1472 - 1479
  • [40] Patterns of screening and access to care in women diagnosed with breast cancer in a safety-net system
    Kanjwal, Shifa
    Su, Malcolm
    Hopson, Madeleine
    Kashanian, Sarah
    Ahn, Chul
    Syed, Samira K.
    Ramos, Glenda Maria Delgado
    Unni, Nisha
    Sadeghi, Navid
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)